We are live on ! Find out more
ICRM

Insight Capital Research & Management Portfolio holdings

AUM $177M
1-Year Est. Return 72%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+72%
3 Year Est. Return
+286.87%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$287M
AUM Growth
-$36.1M
Cap. Flow
-$54.1M
Cap. Flow %
-18.85%
Top 10 Hldgs %
19.69%
Holding
136
New
42
Increased
4
Reduced
48
Closed
39

Top Buys

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$4.66M
2
WAGE
WageWorks, Inc.
WAGE
+$4.51M
3
FN icon
Fabrinet
FN
+$4.43M
4
AMAT icon
Applied Materials
AMAT
+$3.52M
5
ORBK
Orbotech Ltd
ORBK
+$3.49M

Top Sells

Rank Stock Value
1
MXL icon
MaxLinear
MXL
+$9.93M
2
EBS icon
Emergent Biosolutions
EBS
+$7.39M
3
EPAM icon
EPAM Systems
EPAM
+$5.83M
4
AMN icon
AMN Healthcare
AMN
+$5.71M
5
AAPL icon
Apple
AAPL
+$5.27M

Sector Composition

Rank Sector Weight
1 Technology 17.59%
2 Industrials 17.28%
3 Healthcare 16.68%
4 Consumer Discretionary 12.34%
5 Real Estate 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
51
Apple
AAPL
$4.54T
$2.85M 0.99%
119,180
-211,920
-64% -$5.27M
THO icon
52
Thor Industries
THO
$4.14B
$2.81M 0.98%
+43,342
New +$2.77M
TJX icon
53
TJX Companies
TJX
$177B
$2.79M 0.97%
72,210
-9,086
-11% -$347K
BMY icon
54
Bristol-Myers Squibb
BMY
$130B
$2.78M 0.97%
+37,759
New +$2.67M
LFUS icon
55
Littelfuse
LFUS
$11.7B
$2.76M 0.96%
23,320
-3,143
-12% -$366K
YUM icon
56
Yum! Brands
YUM
$41.6B
$2.71M 0.94%
+45,418
New +$2.68M
CORE
57
DELISTED
Core Mark Holding Co., Inc.
CORE
$2.66M 0.93%
+56,818
New +$2.41M
TMO icon
58
Thermo Fisher Scientific
TMO
$214B
$2.64M 0.92%
+17,851
New +$2.63M
HMSY
59
DELISTED
HMS Holdings Corp.
HMSY
$2.62M 0.91%
+148,515
New +$2.4M
PRAH
60
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.6M 0.91%
+62,387
New +$2.87M
HD icon
61
Home Depot
HD
$352B
$2.56M 0.89%
20,090
-14,031
-41% -$1.86M
SYNH
62
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.56M 0.89%
67,202
-7,287
-10% -$320K
AMN icon
63
AMN Healthcare
AMN
$1.27B
$2.53M 0.88%
63,319
-154,459
-71% -$5.71M
JNJ icon
64
Johnson & Johnson
JNJ
$621B
$2.52M 0.88%
20,783
-6,126
-23% -$696K
ADC icon
65
Agree Realty
ADC
$9.46B
$2.5M 0.87%
+51,766
New +$2.18M
BFAM icon
66
Bright Horizons
BFAM
$3.97B
$2.47M 0.86%
37,288
-29,659
-44% -$1.93M
WST icon
67
West Pharmaceutical
WST
$24.7B
$2.47M 0.86%
+32,551
New +$2.37M
EW icon
68
Edwards Lifesciences
EW
$51.2B
$2.45M 0.86%
+73,812
New +$2.53M
STZ icon
69
Constellation Brands
STZ
$22.3B
$2.44M 0.85%
14,728
-2,870
-16% -$449K
TRNO icon
70
Terreno Realty
TRNO
$7.34B
$2.41M 0.84%
+93,254
New +$2.21M
BKNG icon
71
Booking.com
BKNG
$160B
$2.4M 0.84%
48,100
-7,725
-14% -$401K
FIX icon
72
Comfort Systems
FIX
$61.1B
$2.35M 0.82%
72,109
-16,471
-19% -$525K
ELLI
73
DELISTED
Ellie Mae Inc
ELLI
$2.31M 0.81%
+25,251
New +$2.15M
VMC icon
74
Vulcan Materials
VMC
$37.2B
$2.29M 0.8%
19,058
-31,939
-63% -$3.62M
DG icon
75
Dollar General
DG
$28B
$2.26M 0.79%
24,070
-25,103
-51% -$2.16M
1 2
3
4 5

Similar funds

YP
YG Partners New York $189M AUM 21.34% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
BSWMG
Barrington Strategic Wealth Management Group Chicago, Illinois $198M AUM 10.24% 1-Year Est. Return
OW
Orbis World Road Town, Tortola, British Virgin Islands $154M AUM 2.78% 1-Year Est. Return
QI
Quotient Investors New York $146M AUM 15.98% 1-Year Est. Return
TGCM
Tukman Grossman Capital Management Larkspur, California $133M AUM 15.1% 1-Year Est. Return
TG
Threshold Group Seattle, Washington $125M AUM 14.58% 1-Year Est. Return
MIM
Midwest Investment Management Cleveland, Ohio $121M AUM 20.45% 1-Year Est. Return

Insight Capital Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, Insight Capital Research & Management held 136 positions worth $287M, down 11% from $323M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Insight Capital Research & Management withdrew a net $54.1M in Q2 2016, closing 39 positions and reducing 48 holdings. Its most notable exit was MaxLinear, an estimated $9.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Insight Capital Research & Management opened a new position in Align Technology worth $4.91M.

  • Insight Capital Research & Management's largest Q2 2016 buy was Align Technology: 60,951 shares worth $4.91M.
  • Insight Capital Research & Management added most to Vail Resorts in Q2 2016, an estimated $1.95M increase.
  • Insight Capital Research & Management's biggest Q2 2016 reduction was AMN Healthcare, cutting an estimated $5.71M.
  • Insight Capital Research & Management fully exited MaxLinear in Q2 2016, selling an estimated $9.93M.
  • Insight Capital Research & Management's ten largest holdings make up 20% of its $287M portfolio in Q2 2016.
  • Insight Capital Research & Management opened 42 new positions and closed 39 in Q2 2016.
  • Insight Capital Research & Management's portfolio value fell 11% quarter-over-quarter to $287M.

Based on Insight Capital Research & Management's 13F filing for Q2 2016, filed 27 Jul 2016.